CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Developing and commercializing active ingredients from natural sources for healthcare and personal care industries.
Learn More about our ProductsPGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGXTSX Venture
CZO
Change
Volume
Day Range
52 Week Range
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Ceapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results and Provides Corporate Update
Aug 29, 2023 | Read More
Ceapro Extends Exclusive International Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise
Aug 25, 2023 | Read More
Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation
Jul 18, 2023 | Read More
Ceapro to Participate in the Virtual Investor Summer Spotlight Series
Jul 5, 2023 | Read More